IN8bio, Inc.

NASDAQ:INAB

0.2802 (USD) • At close January 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q22018 Q1
Revenue 0003.748000000000000000000000
Cost of Revenue 00.6310.6320.6270.6470.6370.590.3510.2460.2740.2320.0890.05700.16500.02200000000
Gross Profit 0-0.631-0.6323.121-0.647-0.637-0.59-0.351-0.246-0.274-0.232-0.089-0.0570-0.1650-0.02200000000
Gross Profit Ratio 0000.833000000000000000000000
Reseach & Development Expenses 3.3095.1564.9034.5223.7864.1344.3853.9224.2553.5042.3812.6871.352.0641.2451.4851.0571.7841.0520.7150.7150.4640.4640.1450.145
General & Administrative Expenses 2.7323.5333.7423.0763.3833.5813.473.8763.1443.6753.7643.1622.0410.9861.1180.8260.6241.090.6390.6380.6380.7160.7160.3560.356
Selling & Marketing Expenses 000-0.627000000000000000000000
SG&A 2.7323.5333.7422.4493.3833.5813.473.8763.1443.6753.7643.1622.0410.9861.1180.8260.6241.090.6390.6380.6380.7160.7160.3560.356
Other Expenses 1.045-0.0600.3300-0.3300000000000000-2.533-2.533-1.002-1.002
Operating Expenses 7.0868.6298.6456.9717.1697.7157.5257.7987.3997.1796.1455.8493.3913.052.3632.3111.6812.8741.6911.3541.3541.2141.214-0.501-0.501
Operating Income -7.086-8.629-8.562-7.598-7.169-7.715-7.525-7.798-7.399-7.179-6.145-5.849-3.391-3.05-2.363-2.311-1.681-2.874-1.691-1.353-1.353-1.18-1.18-0.501-0.501
Operating Income Ratio 000-2.027000000000000000000000
Total Other Income Expenses Net 0000.33000000000000000-0.001-0.001-0.034-0.034-0.019-0.019
Income Before Tax -7.086-8.629-8.562-7.598-7.169-7.715-7.525-7.798-7.399-7.179-6.145-5.849-3.391-3.05-2.363-2.311-1.681-2.874-1.691-1.354-1.354-1.214-1.214-0.52-0.52
Income Before Tax Ratio 000-2.027000000000000000000000
Income Tax Expense 00-0.632-7.598-0.6470.515-0.590.2960.219000.1450.142-0.715000000.1960.196-0.017-0.017-0.016-0.016
Net Income -7.086-8.629-8.562-7.598-7.169-7.715-6.935-7.798-7.399-7.179-6.145-5.849-3.391-3.05-2.363-2.311-1.681-2.874-1.691-1.55-1.55-1.407-1.407-0.52-0.52
Net Income Ratio 000-2.027000000000000000000000
EPS -0.15-0.19-0.2-0.21-0.23-0.27-0.28-0.32-0.34-0.38-0.33-0.44-0.25-0.16-0.16-0.12-0.087-0.19-0.11-0.48-0.48-0.16-0.16-0.084-0.084
EPS Diluted -0.15-0.19-0.2-0.21-0.23-0.27-0.28-0.32-0.34-0.38-0.33-0.44-0.25-0.16-0.16-0.12-0.087-0.19-0.11-0.48-0.48-0.16-0.16-0.084-0.084
EBITDA -5.351-7.998-8.013-7.301-6.522-7.078-6.935-7.447-7.153-6.905-5.913-5.76-3.334-2.86-2.198-2.289-1.659-2.852-1.669-1.33-1.33-1.155-1.155-0.493-0.493
EBITDA Ratio 000-1.86000000000000000000000